Abstract
The incidence of inflammatory bowel disease is rising in general population, especially in adolescence and early adulthood, and consequently, it is rising in pregnant population. Interestingly the severity and progression of the disease depend on the disease activity during pregnancy. Therefore, it is mandatory to have a patient in a remission before planned pregnancy for minimization of the possibility of the disease progression and complications during pregnancy. When inflammatory bowel disease during pregnancy is active, an additional problem is the use of immunomodulatory and biologic agents which can influence fetal development. On the other hand, prolonged infection during pregnancy increases the rate of preterm labor, fetus small for gestational age, and other obstetric complications. An additional problem is pouch surgery before and during pregnancy because functional results can be lower due to the compression of growing uterus. Also, type of delivery could be influenced by the pouch surgery and pouch function at the time of delivery.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fabry W, editor. Observations chirurgiques. Traduites par un de Medicin. Geneve; 1669.
Crohn BB, Ginzburg L, Oppenheimer G. Regional ileitis. A pathological and clinical entity. JAMA. 1932;99:1323–9.
Thomas GA, Millar-Jones D, Rhodes J, et al. Incidence of Crohn’s disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol. 1995;7:401–5.
Logan R. Inflammatory bowel disease incidence: up, down or unchanged? Gut. 1998;42:309–11.
Armitage E, Drummond H, Ghosh S, et al. Incidence of juvenile-onset Crohn’s disease in Scotland. Lancet. 1999;353:1496–7.
Gunesh S, Thomas GA, Williams G, et al. The incidence of Crohn’s disease in Cardiff over the last 75 years: an update for 1996-2005. Aliment Pharmacol Ther. 2008;27:211–9.
Munkholm P. Crohn’s disease—occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull. 1997;44:287–302.
Baiocco PJ, Korelitz B. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol. 1984;6:211–6.
Heetun ZS, Byrnes C, Neary P, et al. Review article: reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther. 2007;26:513–33.
Babson W. Terminal ileitis with obstruction and abscess complicating pregnancy. N Engl J Med. 1946;235:544–7.
Nelson JL, Hughes KA, Smith A, et al. Maternal-fetal disparity in HLA class II alloantigens and pregnancy-induced amelioratiion of rheumatoid arthritis. N Engl J Med. 1993;329:466–71.
Kane S, Kisiel J, Shih L, et al. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am J Gastroenterol. 2004;99:1523–6.
Fevoid HL, Hisaw FL, Meyer R. The relaxative hormone of corpus luteum. Its purification and concentration. J Am Chem Soc. 1930;52:3340–8.
Munkholm P. Pregnancy, fertility, and disease course in patients with Crohn’s disease and ulcerative colitis. Eur J Intern Med. 2000;11:215–21.
Nwokolo CU, Tan WC, Andrews HA, et al. Surgical resections in parous patients with distal ileal and colonic Crohn’s disease. Gut. 1994;35:220–3.
Peters RW, Fry RD, Fleshman JW, et al. Multiple blood transfusions reduce the recurrence rate of Crohn’s disease. Dis Colon Rectum. 1992;32:749–53.
Crohn BB, Yarnis H, Regional KB. ileitis complicating pregnancy. Gastroenterology. 1956;31:615–28.
Norton RA, Patterson J. Pregnancy and regional ileitis. Obstet Gynecol. 1972;40:711–2.
Khosla R, Willoughby CP, Jewell DP. Crohn’s disease and pregnancy. Gut. 1984;25:52–6.
Abramson D, Jankelson IR, Milner L. Pregnancy in idiopathic ulcerative colitis. Am J Obstet Gynecol. 1951;61:121–9.
Thomas GA, Rhodes J, Green JT, et al. Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J. 2000;76:273–9.
Sorokin J. Pregnancy and inflammatory bowel disease. Obstet Gynecol. 1983;62:247–51.
Agret F, Cosnes J, Hassani Z, et al. Impact of pregnancy on the clinical activity of Crohn’s disease. Aliment Pharmacol Ther. 2005;21:509–13.
Triantafillidis JK, Malgarinos G, Gikas A, et al. Pregnancy and inflammatory bowel disease in Greece: a prospective study of seven cases in a single hospital setting. Ann Gastroenterol. 2007;20:29–34.
Smink M, Lotgering FK, Albers L, et al. Effect of childbirth on the course of Crohn’s disease; results from a retrospective cohort study in the Netherlands. BMC Gastroenterol. 2011;11:6.
Summers RW, Switz DM, Sessions JT, et al. National Cooperative Crohn’s Disease Study: results of drug treatment. Gastroenterology. 1979;77:847–69.
Rogers RG, Katz VL. Course of Crohn’s disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol. 1995;12:262–4.
Hanan I. Inflammatory bowel disease in the pregnant woman. Compr Ther. 1993;19:91–5.
Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch Gynecol Obstet. 2004;270:79–85.
Pedersen N, Bortoli A, Duricova D, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013;38:501–12.
Alstead EM, Nelson-Piercy C. Inflammatory bowel disease in pregnancy. Gut. 2003;52:159–61.
Nielsen OH, Andreasson B, Bondesen S, et al. Pregnancy in Crohn’s disease. Scand J Gastroenterol. 1984;19:724–32.
Morales M, Berney T, Jenny A, et al. Crohn’s disease as a risk factor for the outcome of pregnancy. Hepato Gastroenterol. 2000;47:1595–8.
Moffatt DC, Ilnyckyj A, Bernstein C. A population-based study of breastfeeding in inflammatory bowel disease: initiation, duration, and effect on disease in the postpartum period. Am J Gastroenterol. 2009;104:2517–23.
Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2005;100:102–5.
Fonager K, Sørensen HT, Olsen J, et al. Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries. Am J Gastroenterol. 1998;93:2426–30.
Hanan IM, Kirsner JB. Inflammatory bowel disease in the pregnant woman. Clin Perinatol. 1985;12:669–82.
Mogadam M, Korelitz BI, Ahmed SW, et al. The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol. 1981;75:265–9.
Alstead EM. Inflammatory bowel disease in pregnancy. Postgrad Med J. 2002;78:23–6.
Subhani JM, Hamiliton MI. Review article: the management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther. 1998;12:1039–53.
Castiglione F, Pignata S, Morace F, et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol. 1996;28:199–204.
Riis L, Vind I, Politi P, et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2006;101:1539–45.
Korelitz BI. Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am. 1992;21:827–34.
Blair JSG, Allen N. Crohn’s disease presenting acutely during pregnancy. J Obstet Gynaecol Br Commonw. 1962;69:648–51.
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.
Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–53.
Solomon MJ, Deva AK, Corcoran SJ, Gallagher N. Postpartum avulsion of the terminal ileal wall in Crohn’s disease. Aust N Z J Surg. 1996;66:849–51.
Amos JD, Schorr SJ, Norman P, et al. Laparoscopic surgery during pregnancy. Am J Surg. 1996;171:435–7.
Cicarelli LM, Perroni AG, Zugaib M, et al. Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-α, interleukin-1β, and interleukin-8 during and after delivery. Mediators Inflamm. 2005;2005:96–100.
de Villiers WJ, Louw JP, Strachan A, et al. C-reactive protein and serum amyloid A protein in pregnancy and labour. BJOG. 1990;97:725–30.
Nesin M, Cunningham-Rundles S. Cytokines and neonates. Am J Perinatol. 2000;17:393–404.
Nguyen GC, Kaplan GG, Harris M, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443–50.
Issa M, Ananthakrishnan AN, Binion D. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1432–42.
Shoenut JP, Semelka RC, Silverman R, et al. MRI in the diagnosis of Crohn’s disease in two pregnant women. J Clin Gastroenterol. 1993;17:244–7.
Stern MD, Kopylov U, Ben-Horin S, et al. Magnetic resonance enterography in pregnant women with Crohn’s disease: case series and literature review. BMC Gastroenterol. 2014;14:1–9.
Cappell MS, Sidhom O. Multicenter, multiyear study of safety and efficacy of flexible sigmoidoscopy during pregnancy in 24 females with follow-up of fetal outcome. Dig Dis Sci. 1995;40:472–9.
Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut. 2006;55:1198–206.
Stengel JZ, Arnold HL. Is infliximab safe to use while breastfeeding? World J Gastroenterol. 2008;14(19):3085–7.
Habal FM, Ravindran NC. Management of inflammatory bowel disease in the pregnant patient. World J Gastroenterol. 2008;14:1326–32.
Koss CA, Baras DC, Lane S, et al. Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrob Agents Chemother. 2012;56:4800–5.
Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. BJOG. 1998;105:322–7.
Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006;131:283–311.
Gisbert J. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. Inflamm Bowel Dis. 2010;16:881–95.
Osadchy A, Koren G. Cyclosporine and lactation: when the mother is willing to breastfeed. Ther Drug Monit. 2011;33:147–8.
Zeldis J. Pregnancy and inflammatory bowel disease. West J Med. 1989;151:168–71.
Khan AK, Truelove S. Placental and mammary transfer of sulphasalazine. BMJ. 1979;2:1553.
Jarnerot G, Andersen S, Esbjorner E, et al. Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand J Gastroenterol. 1981;16:1049–55.
Esbjorner E, Jarnerot G, Wranne L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand. 1987;76:137–42.
Diav-Citrin O, Park YH, Veerasuntharam G, et al. The safety of mesalazine in human pregnancy: a prospective controlled cohort study. Gastroenterology. 1998;114:23–8.
Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol. 2008;25:271–5.
Marteau P, Tennenbaum R, Elefant E, et al. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther. 1998;12:1101–8.
Bell CM, Habal F. Safety of topical 5-aminosalicylic acid in pregnancy. Am J Gastroenterol. 1997;92:2201–2.
Ito S, Blajchman A, Stephenson M, et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993;68:1393–9.
Nelis G. Diarrhoea due to 5-aminosalicylic acid in breast milk. Lancet. 1989;1:383.
Olsen SF, Østerdal ML, Salvig JD, et al. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. Eur J Clin Nutr. 2007;61:976–85.
Järnerot G. Management of IBD in pregnancy. Res Clin Forum. 1993;15:137–43.
Fielding JF, Cooke W. Pregnancy and Crohn’s disease. BMJ. 1970;2:76–7.
Nielsen OH, Andreasson B, Bondesen S, et al. Pregnancy in ulcerative colitis. Scand J Gastroenterol. 1983;18:735–42.
McEwan H. Ulcerative colitis in pregnancy. Proc R Soc Med. 1972;65:279–81.
Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385–92.
Korelitz B. Pregnancy, fertility, and inflammatory bowel disease. Am J Gastroenterol. 1985;80:365–70.
Modigliani R. Drug therapy for ulcerative colitis during pregnancy. Eur J Gastroenterol Hepatol. 1997;9:854–7.
Willoughby CP, Truelove S. Ulcerative colitis and pregnancy. Gut. 1980;21:469–74.
Homar V, Grosek S, Battelino T. High-dose methylprednisolone in a pregnant woman with Crohn’s disease and adrenal suppression in her newborn. Neonatology. 2008;94:306–9.
Beaulieu DB, Ananthakrishnan AN, Issa M. Budesonide induction and maintenance therapy for Crohn’s disease during pregnancy. Inflamm Bowel Dis. 2009;15:25–8.
Burakoff R, Opper F. Pregnancy and nursing. Gastroenterol Clin N Am. 1995;24:689–98.
Nørgård B, Pedersen L, Fonager K, et al. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther. 2003;17:827–34.
Zlatanic J, Korelitz BI, Rajapakse R, et al. Complications of pregnancy and child development after cessation of treatment with 6-mercaptopurine for inflammatory bowel disease. J Clin Gastroenterol. 2003;36:303–9.
Francella A, Dyan A, Bodian C, et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003;124:9–17.
Coelho J, Beaugerie L, Colombel J, et al. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut. 2011;60:198–203.
Alstead EM, Ritchie JK, Lennard-Jones J, et al. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology. 1990;99:443–6.
O’Connell J. Additional discussion on the safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003;126:1493.
Kucerova M, Kocandrle V, Matousek V, et al. Chromosomal aberrations and sister-chromatid exchanges (SCEs) in patients undergoing long-term Imuran therapy. Mutat Res. 1982;94:501–9.
Rajapakse RO, Korelitz BI, Zlatanic J, et al. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol. 2000;95:684–8.
Akbari M, Shah S, Velayos F, et al. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:15–22.
Committee on Drugs AA of Pediatrics. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776–9.
Angelberger S, Reinisch W, Messerschmidt A, et al. Longterm follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis. 2011;5:95–100.
Christensen LA, Dahlerup JF, Nielsen M. Azathioprine treatment during lactation. Aliment Pharmacol Ther. 2008;28:1209–13.
Shibolet O, Regushevskaya E, Brezis M, et al. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev. 2005;(1):CD004277.
Jayaprakash A, Gould S, Lim AG, et al. Use of cyclosporin in pregnancy. Gut. 2004;53:1386–7.
Bertschinger P, Himmelmann A, Risti B, et al. Cyclosporine treatment of severe ulcerative colitis during pregnancy. Am J Gastroenterol. 1995;90:330.
Branche J, Cortot A, Bourreille A, et al. Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy. Inflamm Bowel Dis. 2009;15:1044–8.
Reindl W, Schmid RM, Huber W. Cyclosporin A treatment of steroid-refractory ulcerative colitis during pregnancy: report of two cases. Gut. 2007;56:1019.
Lahiff C, Moss A. Cyclosporine in the management of severe ulcerative colitis while breast-feeding. Inflamm Bowel Dis. 2011;17:E78.
Angelberger S, Reinisch W, Dejaco C. Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy. Gut. 2006;55:1364–5.
Van Assche G, Vermeire S, Rutgeerts P. Treatment of severe steroid refractory ulcerative colitis. World J Gastroenterol. 2008;14:5508–11.
Moss AC, Peppercorn M. Steroid-refractory severe ulcerative colitis: what are the available treatment options? Drugs. 2008;68:1157–67.
Moretti ME, Sgro M, Johnson D, et al. Cyclosporine excretion into breast milk. Transplantation. 2003;75:2144–6.
Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003;21:3365–9.
Kane SV, Acquah L. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol. 2009;104:228–33.
Mahadevan U, Kane S, Sandborn WJ, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn’s disease. Alimentary Pharmacol Ther. 2005;21:733–8.
Vasiliauskas EA, Church JA, Silverman N, et al. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255–8.
Zelinkova Z, de Haar C, de Ridder L, et al. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther. 2011;33:1053–8.
Kane S, Ford J, Cohen R, et al. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn’s disease before and after delivery. J Clin Gastroenterol. 2009;43:613–6.
Friedman S, Regueiro MD. Pregnancy and nursing in inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:265–73.
Mahadevan U, Cucchiara S, Hyams J, et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn’s and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol. 2011;106:214–24.
Rahier JF, Moutschen M, Van Gompel A, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology. 2010;49:1815–27.
Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the TREATTM registry. Am J Gastroentrol. 2012;107:1409–22.
Katz JA, Antoni C, Keenan GF, et al. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn’s disease and rheumatoid arthritis. Am J Gastroenterol. 2004;99:2385–92.
Caprilli R, Gassull MA, Escher J, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut. 2006;55:i36–58.
Sánchez Munoz D, Hoyas Pablos E, Ramirez Martin Del Campo M, et al. Term pregnancy in a patient with Crohn’s disease under treatment with adalimumab. Gastroenterol Hepatol. 2005;28:435.
Coburn LA, Wise PE, Schwartz D. The successful use of adalimumab to treat active Crohn’s disease of an ileoanal pouch during pregnancy. Dig Dis Sci. 2006;51:2045–7.
Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut. 2005;54:890.
Sills ES, Perloe M, Tucker MJ, et al. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol. 2001;46:366–8.
Ostensen M, Eigenmann G. Etanercept in breast milk. J Rheumatol. 2004;31:1017–8.
Peltier M, James D, Ford J, et al. Infliximab levels in breastmilk of a nursing Crohn’s patient. Am J Gastroenterol. 2001;96:S312.
Srinivasan R, Akobeng A. Thalidomide and thalidomide analogues for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2009;(2):CD007350.
Akobeng AK, Stokkers P. Thalidomide and thalidomide analogues for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2009;(2):CD007351.
Rahimi R, Nikfar S, Rahimi F, et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn’s disease. Dig Dis Sci. 2008;53:2524–31.
Rahimi R, Nikfar S, Rezaie A, et al. meta-analysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for prevention of disease relapse and maintenance of remission. Arch Med Sci. 2008;4:185–90.
Elias J, Bozzo P, Einarson A. Are probiotics safe for use during pregnancy and lactation? Can Fam Physician. 2011;57:299–301.
Cox KL, Byrne WJ, Ament M. Home total parenteral nutrition during pregnancy: a case report. JPEN J Parenter Enteral Nutr. 1981;5:246–9.
Tresadern JC, Falconer GF, Turnberg LA, et al. Successful completed pregnancy in a patient maintained on home parenteral nutrition. BMJ. 1983;286:602–3.
Main AN, Shenkin A, Black WP, et al. Intravenous feeding to sustain pregnancy in patient with Crohn’s disease. BMJ. 1981;283:1221–2.
Teahon K, Pearson M, Levi AJ, et al. Elemental diet in the management of Crohn’s disease during pregnancy. Gut. 1991;32:1079–81.
Jones V. Comparison of total parenteral nutrition and elemental diet in induction of remission of Crohn’s disease. Long-term maintenance of remission by personalized food exclusion diets. Dig Dis Sci. 1987;32:100S–7S.
O’Morain C, Segal AW, Levi A. Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. BMJ. 1984;288:1859–62.
Goettler CE, Stellato T. Initial presentation of Crohn’s disease in pregnancy. Dis Colon Rectum. 2003;46:406–10.
Hill J, Clark A, Scott NA. Surgical treatment of acute manifestations of Crohn’s disease during pregnancy. J R Soc Med. 1997;90:64–6.
Dozois EJ, Wolff BG, Tremaine WJ, et al. Maternal and fetal outcome after colectomy for fulminant ulcerative colitis during pregnancy: case series and literature review. Dis Colon Rectum. 2006;49:64–73.
Boreham PF, Soltau D. Pregnancy and Crohn’s disease. BMJ. 1970;2:541.
Soltau D. Crohn’s disease and pregnancy. BMJ. 1972;3:760–1.
Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease—a population-based cohort study. Am J Obstet Gynecol. 1997;177:942–6.
Nguyen GC, Boudreau H, Harris ML, et al. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2009;7:329–34.
Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56:830–7.
Kwee A, Elferink-Stinkens PM, Reuwer PJ, et al. Trends in obstetric interventions in the Dutch obstetrical care system in the period 1993-2002. Eur J Obstet Gynecol Reprod Biol. 2007;132:70–5.
Counihan TC, Roberts PL, Schoetz DJ, et al. Fertility and sexual and gynecologic function after ileal pouch-anal anastomosis. Dis Colon Rectum. 1994;37:1126–9.
Nelson H, Dozois RR, Kelly K, et al. The effect of pregnancy and delivery on the ileal pouch–anal anastomosis functions. Dis Colon Rectum. 1989;32:384–8.
Metcalf AM, Dozois RR, Beart RW Jr, et al. Pregnancy following ileal pouch-anal anastomosis. Dis Colon Rectum. 1985;28:859–61.
Juhasz ES, Fozard B, Dozois R, et al. Ileal pouch-anal anastomosis function following childbirth. Dis Colon Rectum. 1995;38:159–65.
Remzi FH, Gorgun E, Bast J, et al. Vaginal delivery after ileal pouch–anal anastomosis: a word of caution. Dis Colon Rectum. 2005;48:1691.
Ananthakrishnan AN, Cheng A, Cagan A, et al. Mode of childbirth and long-term outcomes in women with inflammatory bowel diseases. Dig Dis Sci. 2015;60:471–7.
Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis. 2010;4:63–101.
Ilnyckyji A, Blanchard JF, Rawsthorne P, et al. Perianal Crohn’s disease and pregnancy: role of the mode of delivery. Am J Gastroenterol. 1999;94:3274–8.
Beniada A, Benoist G, Maurel J, et al. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod. 2005;34:581–8.
Brandt LJ, Estabrook SG, Reinus J. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn’s disease. Am J Gastroenterol. 1995;90:1918–22.
Watson WJ, Gaines TE. Third-trimester colectomy for severe ulcerative colitis. A case report. J Reprod Med Obstet Gynecol. 1987;32:869–72.
Moser MA, Okun NB, Mayes DC, et al. Crohn’s disease, pregnancy, and birth weight. Am J Gastroenterol. 2000;95:1021–6.
De Dombal FT, Burton IL, Goligher J. Crohn’s disease and pregnancy. BMJ. 1972;3:550–3.
Porter RJ, Stirrat G. The effects of inflammatory bowel disease on pregnancy: a case-controlled retrospective analysis. BJOG. 1986;93:1124–31.
Fielding J, Prior P, Waterhouse J, et al. Unpublished observations; 1969.
Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn’s Relapse Prevention Trial Study Group. Gastroenterology. 1994;106:287–96.
Lask B, Jenkins J, Nabarro L, et al. Psychosocial sequelae of stoma surgery for inflammatory bowel disease in childhood. Gut. 1987;28:1257–60.
Burnham WR, Lennard-Jones JE, Brooke BN. Sexual problems among married ileostomists. Survey conducted by The Ileostomy Association of Great Britain and Ireland. Gut. 1977;18:673–7.
Moody GA, Mayberry JF. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion. 1993;54:256–60.
Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn’s disease: a case control study by European collaborative group. Gut. 1986;27:821–5.
Moody G, Probert CS, Srivastava EM, et al. Sexual dysfunction amongst women with Crohn’s disease: a hidden problem. Digestion. 1992;52:179–83.
Saha S, Zhao YQ, Shah S, et al. Menstrual cycle changes in women with inflammatory bowel disease: a study from the Ocean State Crohn’s and Colitis Area Registry. Inflamm Bowel Dis. 2014;20:534–40.
Weber AM, Ziegler C, Belinson J, et al. Gynecologic history of women with inflammatory bowel disease. Obstet Gynecol. 1995;86:843–7.
Kane SV, Sable K, Hanauer S. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol. 1998;93:1867–72.
Bernstein MT, Graff LA, Targownik L, et al. Gastrointestinal symptoms before and during menses in women with IBD. Aliment Pharmacol Ther. 2012;36:135–44.
Care AC on AH. ACOG Committee Opinion No. 349, November 2006: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol. 2006;108:1323–8.
Willman EA, Collins WP, Clayton S. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. BJOG. 1976;83:337–41.
Weber AM, Belinson J. Inflammatory bowel disease—a complicating factor in gynecologic disorders? Medscape Womens Health. 1997;2:4.
Baird DD, Narendranathan M, Sandler RS. Increased risk of pre-term birth for women with inflammatory bowel disease. Gastroenterology. 1990;99:987–94.
Hudson M, Flett G, Sinclair T, et al. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet. 1997;58:229–37.
Larzilliere I, Beau P. [Chronic inflammatory bowel disease and pregnancy. Case control study]. Gastroenterol Clin Biol. 1998;22:1056–60.
Orholm M, Fonager K, Sorensen HT. Risk of ulcerative colitis and Crohn’s disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol. 1999;94:3236–8.
Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991;324:84–8.
Peeters M, Nevans H, Baert F, et al. Familial aggregation in Crohn’s disease. Increased age, adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996;111:597–603.
Yang H, McElree C, Roth MP, et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34:517–24.
Bennett RA, Rubin PH, Present D. Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology. 1991;100:1638–43.
Klement E, Cohen RV, Boxman J, et al. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342–52.
Mahadevan U, Sandborn WJ, Li DK, et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007;133:1106–12.
Nørgård B, Fonager K, Sørensen HT, et al. Birth outcomes of women with ulcerative colitis: a nationwide danish cohort study. Am J Gastroenterol. 2000;95:3165–70.
Dominitz JA, Young JCC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol. 2002;97:641–8.
Bush MC, Patel S, Lapinski RH, et al. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med. 2004;15:237–41.
Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol. 1989;160:998–1001.
Reddy SI, Wolf J. Management issues in women with inflammatory bowel disease. J Am Osteopat Assoc. 2001;101:S17–23.
Reddy D, Murphy SJ, Kane SV, et al. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol. 2008;103:1203–9.
Gould SR, Brash AR, Conolly ME, et al. Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins Med. 1981;6:165–82.
Lamah M, Scott HJ. Inflammatory bowel disease and pregnancy. Int J Color Dis. 2002;17:216–22.
Menon R, Velez DR, Thorsen P, et al. Ethnic differences in key candidate genes for spontaneous preterm birth: TNF-alpha and its receptors. Hum Hered. 2006;62:107–18.
Miller J. Inflammatory bowel disease in pregnancy: a review. J R Soc Med. 1986;79:221–5.
Nørgård B, Hundborg HH, Jacobsen BA, et al. Disease activity in pregnant women with crohn’s disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol. 2007;102:1947–54.
Schofield PF, Turnbull RB, Hawk W. Crohn’s disease and pregnancy. BMJ. 1970;2:364.
Eidelman AI. Breastfeeding and the use of human milk: an analysis of the American Academy of Pediatrics 2012 Breastfeeding Policy Statement. Breastfeed Med. 2012;7:323–4.
Larsen LA, Ito S, Koren G. Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother. 2003;37:1299–306.
Orholm M, Binder V, Sorensen T, et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol. 2000;35:1075–81.
Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988;29:990–6.
Martimbeau PW, Welch JS, Weiland LH. Crohn’s disease and pregnancy. Am J Obstet Gynecol. 1975;122:746–9.
Wilks S. Morbid appearances in the intestine of Miss Bankes. Lond Med Gaz. 1859;2:264.
Gossage AM, Price FW. Proc R Soc Med. 1909;2:151–6.
MacDougall I. Ulcerative colitis and pregnancy. Lancet. 1956;2:641–3.
Holzbach R. Toxic megacolon in pregnancy. Am J Dig Dis. 1969;14:908–10.
Flatmark AL, Nordöy A, Gjone E. Radical surgery lor ulcerative colitis during pregnancy. Scand J Gastroenterol. 1971;6:45–7.
Webb MJ, Sedlack R. Ulcerative colitis in pregnancy. Med Clin North Am. 1974;58:823–7.
Peskin GW, Davis A. Acute fulminating ulcerative colitis with colonic distension. Surg Gynecol Obstet. 1960;110:269–76.
Marshak RH, Korelitz BJ, Klein S, et al. Toxic dilatation of the colon in the course of ulcerative colitis. Gastroenterology. 1960;38:165–80.
Maddix B. Ulcerative colitis and pregnancy. Minn Med. 1962;45:1097–102.
Jalan KN, Sircus W, Card W, et al. An experience of ulcerative colitis. I. Toxic dilatation in 55 cases. Gastroenterology. 1969;57:68–82.
Ritchie JK. Ileostomy and excisional surgery for chronic inflammatory disease of the colon: a survey of one hospital region. Gut. 1971;12:528–40.
Cooksey G, Gunn A, Wotherspoon W. Surgery for acute ulcerative colitis and toxic megacolon during pregnancy. Br J Surg. 1985;72:547.
Herrington A, Gala R, Beck DE, et al. Bowel obstruction in a pregnant patient with a restorative proctocolectomy and ileoanal J-pouch: a case report. Ochsner J. 2012;12:170–2.
Walker M, Sylvain J, Stern H. Bowel obstruction in a pregnant patient with ileal pouch-anal anastomosis. Can J Surg. 1997;40:471–3.
Edwards FC, Truelove S. The course and prognosis of ulcerative colitis. Gut. 1963;4:299–315.
Katz JA, Pore G. Inflammatory bowel disease and pregnancy. Inflamm Bowel Dis. 2001;7:146–57.
Siddiqui AA, Mahboob A, Ansari M, et al. Effect of pregnancy on the disease activity in ulcerative colitis. J Postgrad Med Inst. 2011;25:314–7.
Vender RJ, Spiro HM. Inflammatory bowel disease and pregnancy. J Clin Gastroenterol. 1982;4:231–49.
Jarnerot G. Fertility, sterility and pregnancy in chronic inflammatory bowel disease. Scand J Gastroenterol. 1982;17:1–4.
De Dombal FT, Watts JM, Watkinson G, et al. Ulcerative colitis and pregnancy. Lancet. 1965;2:599–602.
Mogadam M, Dobbins WO, Korelitz BI, et al. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology. 1981;80:72–6.
Donaldson RM Jr. Management of medical problems in pregnancy—inflammatory bowel disease. N Engl J Med. 1985;312:1616–9.
Levy N, Roisman I, Teodor I. Ulcerative colitis in pregnancy in Israel. Dis Colon Rectum. 1981;24(5):351–4.
Sykes L, MacIntyre DA, Yap X, et al. Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy•D,(12,14)prostaglandin J2. Mediators Inflamm. 2012;2012:416739.
Spina V, Giovannini M, Fabiani C, et al. Postpartum complications in a patient with a previous proctocolectomy and ileo-pouch-anal anastomosis (IPAA) for ulcerative colitis. J Prenat Med. 2012;6:31–3.
Mourelle M, Casellas F, Guarner F, et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology. 1995;109:1497–502.
Guslandi M. Nitric oxide and inflammatory bowel diseases. Eur J Clin Invest. 1998;28:904–7.
Dan U, Rabinovici J, Koller M, et al. Iatrogenic mechanical ileus due to over-distended uterus. Gynecol Obstet Invest. 1988;25:143–4.
Quddus A, Martin-Perez B, Schoonyoung H, et al. Toxic megacolon during pregnancy in ulcerative colitis: a case report. Int J Surg Case Rep. 2015;11:83–6.
Chartrand-Lefebvre C, Heppel J, Potvin C, et al. Outcome of toxic megacolon during pregnancy. Can J Gastroenterol. 1990;4:230–4.
Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1201–5.
Rouphael NG, O’Donnell JA, Bhatnagar J, et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol. 2008;198:e1–6.
Pépin J, Valiquette L, Alary M, et al. Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466–72.
Gourevitch D, Hawkey P. Clostridium difficile infection and surgery. Br J Surg. 2009;96:3–4.
Shi HY, Ng SC, Tsoi K, et al. The role of capsule endoscopy in assessing mucosal inflammation in ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2014;25:1–8.
Ooi BS, Remzi FH, Fazio VW. Turnbull-blowhole colostomy for toxic ulcerative colitis in pregnancy: report of two cases. Dis Colon Rectum. 2003;46:111–5.
Greenfield C, Pounder RE, Craft IL, et al. Severe ulcerative colitis during successful pregnancy. Postgrad Med J. 1983;59:459–61.
Anderson JB, Turner GM, Williamson RC. Fulminant ulcerative colitis in late pregnancy and the puerperium. J R Soc Med. 1987;80:492–4.
Orabona R, Valcamonico A, Salemme M, et al. Fulminant ulcerative colitis in a healthy pregnant woman. World J Gastroenterol. 2015;21:6060–4.
Bohe MG, Ekelund GR, Genell S, et al. Surgery for fulminating colitis during pregnancy. Dis Colon Rectum. 1983;26:119–22.
Becker I. Pregnancy and toxic dilatation of the colon. Am J Dig Dis. 1972;17:79–84.
Heppell J, Farkouh E, Dube S, et al. Toxic megacolon, an analysis of 70 cases. Dis Colon Rectum. 1986;29:789–92.
Fazio V. Toxic megacolon in ulcerative colitis and Crohn’s colitis. Clin Gastroenterol. 1980;9:389–407.
Haq AI, Sahai A, Hallwoth S, et al. Synchronous colectomy and caesarean section for fulminant ulcerative colitis: case report and review of the literature. Int J Colorectal Dis. 2006;21:465–9.
Turnbull RB Jr, Hawk WA, Weakley F. Surgical treatment of toxic megacolon. Ileostomy and colostomy to prepare patients for colectomy. Am J Surg. 1971;122:325–31.
Crile GC Jr, Thomas JC. The treatment of acute toxic ulcerative colitis by ileostomy and simultaneous colectomy. Gastroenterology. 1951;19:58–68.
Penna C, Daude F, Parc R, et al. Previous subtotal colectomy with ileostomy and sigmoidostomy improves the morbidity and early functional results after ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum. 1993;36:343–8.
Toiyama Y, Araki T, Yoshiyama S, et al. Fulminant ulcerative colitis during pregnancy successfully treated by three-stage operation. J Gastroenterol. 2004;39:300–1.
Hahnloser D, Pemberton JH, Wolff BG, et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum. 2004;47:1127–35.
Kitayama T, Funayama Y, Fukushima K, et al. Anal function during pregnancy and postpartum after ileal pouch anal anastomosis for ulcerative colitis. Surg Today. 2005;35:211–5.
Ravid A, Richard CS, Spencer LM, et al. Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2002;45(10):1283–8.
Farouk R, Pemberton JH, Wolff B, et al. Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg. 2000;231:919–26.
Pezim M. Successful childbirth after restorative proctocolectomy with pelvic ileal reservoir. Br J Surg. 1984;71:292.
Bradford K, Melmed GY, Fleshner P, et al. Significant variation in recommendation of care for women of reproductive age with ulcerative colitis postileal pouch-anal anastomosis. Dig Dis Sci. 2014;59:1115–20.
Metcalf AM, Dozois RR, Kelly K. Sexual function in women after proctocolectomy. Ann Surg. 1986;204:624–7.
Lepistö A, Sarna S, Tiitinen A, et al. Female fertility and childbirth after ileal pouch–anal anastomosis for ulcerative colitis. Br J Surg. 2007;94:478–82.
Silver RM, Landon MB, Rouse D, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107:1226–32.
Barnes CS, Hayes H. Ulcerative colitis complicating pregnancy and the puerperium. Am J Obstet Gynecol. 1931;22:907–12.
Granchow MI, Benjamin H. Inflammatory colorectal disease and pregnancy. Dis Colon Rectum. 1975;18:706–9.
Banks BM, Korelitz BI, Zetzel L. The course of nonspecific ulcerative colitis: review of twenty years’ experience and late results. Gastroenterology. 1957;32:983–1012.
Schade RR, Van Thiel DH, Gavaler JS. Chronic idiopathic ulcerative colitis. Pregnancy and fetal outcome. Dig Dis Sci. 1984;29:614–9.
Olsen KØ, Joelsson M, Laurberg S, Oresland T. Fertility after ileal pouch–anal anastomosis in women with ulcerative colitis. Br J Surg. 1999;86:493–5.
Ørding Olsen K, Juul S, Berndtsson I, et al. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology. 2002;122:15–9.
Waljee A, Waljee J, Morris AM, et al. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55:1575–80.
Johnson P, Richard C, Ravid A, et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2004;47:1119–26.
Wikland M, Jansson I, Asztély M, et al. Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy. Int J Colorectal Dis. 1990;5:49–52.
Olsen KØ, Juul S, Bülow S, et al. Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg. 2003;90:227–31.
Indar AA, Efron JE, Young-Fadok T. Laparoscopic ileal pouch–anal anastomosis reduces abdominal and pelvic adhesions. Surg Endosc. 2009;23:174–7.
Mortier P, Gambiez L, Karoui M, et al. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin Biol. 2006;30:594–7.
Van Horn C, Barrett P. Pregnancy, delivery, and postpartum experiences of fifty-four women with ostomies. J Wound Ostomy Cont Nurs. 1997;24:151–62.
Bartels SA, D’Hoore A, Cuesta M, et al. Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg. 2012;256:1045–8.
Beyer-Berjot L, Maggiori L, Birnbaum D, et al. A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study. Ann Surg. 2013;258:275–82.
Dubinsky M, Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflamm Bowel Dis. 2008;14:1736–50.
Gorgun E, Remzi FH, Golberg J, et al. Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis: a study of 300 patients. Surgery. 2004;136:795–803.
Oresland T, Palmblad S, Ellström M, et al. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Color Dis. 1994;9:77–81.
Norgard B, Puho E, Pedersen L, et al. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol. 2003;98:2006–10.
Elbaz G, Fich A, Levy A, et al. Inflammatory bowel disease and preterm delivery. Int J Gynaecol Obstet. 2005;90:193–7.
Georgy F. Fulminating ulcerative colitis in pregnancy. Obstet Gynecol. 1974;44:603–6.
Junghanns K. Pregnancy and ulcerative colitis. Langenbecks Arch Chir. 1982;356:285–8.
Boulton R, Hamilton M, Lewis A, et al. Fulminant Ulcerative colitis in pregnancy. Am J Gastroenterol. 1994;89:931–3.
Wilson IA, Dench J, Garrett W. Surgical management of ulcerative colitis in an ongoing pregnancy: report of a case and literature review. Int J Color Dis. 2014;29:271.
Hashim E, Belliveau P. Toxic megacolon in pregnancy: a case report. J Obstet Gynaecol Can. 1998;20:74–7.
Soin B, Thyveetil MD, Desai A. Sub-total colectomy for perforated toxic megacolon in pregnancy. J Obstet Gynaecol. 1998;18:601.
Uchino M, Ikeuchi H, Matsuoka H, et al. Surgery for severe ulcerative colitis during pregnancy: Report of two cases. Case Rep Gastroenterol. 2015;9:74–80.
Rajapakse R, Korelitz BI. Inflammatory bowel disease during pregnancy. Curr Treat Options Gastroenterol. 2001;4:245–51.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Augustin, G. (2018). Acute Inflammatory Bowel Disease. In: Acute Abdomen During Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-319-72995-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-72995-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72994-7
Online ISBN: 978-3-319-72995-4
eBook Packages: MedicineMedicine (R0)